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Abstract Epidermal growth factor (EGF) receptor levels are
known to play a central role in density dependent growth
regulation of normal rat kidney (NRK) fibroblasts. Here we
show that EGF receptor expression is strongly decreased when
NRK cells are cultured under anchorage independent conditions,
and that expression is returned to original levels upon cell re-
adherence. Agents that stimulate anchorage independent growth
(AIG) of NRK cells in the presence of EGF are shown to
upregulate both EGF receptor promoter activity and 125I-EGF
binding capacity. These data show that two aspects of phenotypic
transformation of NRK cells, namely density arrest and AIG,
can both directly be correlated to EGF receptor levels.
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1. Introduction
Cell cycle progression of non-transformed ¢broblasts is
regulated by extracellular signals provided by polypeptide
growth factors and cell adhesion. In contrast, most tumor
cells can proliferate in the absence of externally added growth
factors and without cell anchorage. In a number of non-trans-
formed cell lines, polypeptide growth factors are able to in-
duce phenotypic transformation [1], resulting in loss of density
dependent growth inhibition (DDGI) and induction of an-
chorage independent growth (AIG). AIG is regarded as the
best in vitro correlate for tumorigenic behavior of cells in vivo
[2,3], but the mechanisms underlying AIG are still largely
unknown. Several mechanisms have been proposed to play a
role in the induction of AIG, including increased production
of extracellular matrix proteins such as ¢bronectin [4,5], an
increase in intracellular pH [6], induction of cyclin A [7] and
cyclin D1 [8] expression, activation of cyclin E-cdk2 [8], acti-
vation of a connective tissue growth factor (CTGF) dependent
signalling pathway [9], and modulation of protein-tyrosine
phosphatase activity [10,11].
Normal rat kidney (NRK) ¢broblasts have been widely
used as a model system to study the role of growth factors
in phenotypic transformation. When cultured in the presence
of epidermal growth factor (EGF) as the only growth stimu-
lating hormone, these immortalized cells have a normal phe-
notype and undergo DDGI. In the additional presence of
modulating factors such as retinoic acid (RA) or transforming
growth factor L (TGF-L), which by themselves are not mito-
genic for these cells, density arrested NRK cells become re-
sponsive again to the growth stimulatory e¡ect of EGF, re-
sulting in loss of DDGI [12^15]. It has been established that
the number of EGF receptors in NRK cells decreases with
increasing cell density. Therefore, we have postulated that
EGF treated NRK ¢broblasts become density arrested as a
result of a reduction in EGF receptor levels below a critical
level from which they can be released by addition of such
factors as RA and TGF-L that increase EGF receptor num-
bers [14,15].
In NRK ¢broblasts, a strong parallel has been observed
between the growth factor requirements for induction of
DDGI and AIG [13,16]. Furthermore, mutant NRK cells
have been described in which transforming de¢ciency is
coupled to an inability to proliferate under anchorage inde-
pendent conditions, suggesting that the same mechanisms may
underlie these two aspects of transformation [17]. However,
the role of EGF receptor densities in induction of AIG of
NRK cells has not been studied directly. In the present study,
we show that EGF receptor levels are strongly decreased
under anchorage independent conditions and upregulated
again when cells are allowed to re-adhere. Agents that induce
EGF dependent AIG in NRK cells are shown to upregulate
EGF receptor expression in these non-adhered cells. These
data indicate that EGF receptor levels may not only control
DDGI of NRK cells, but also their ability to grow under
anchorage independent conditions.
2. Materials and methods
2.1. Cell cultures
2.1.1. Adherent cells. NRK cells (clone 49F) were plated at a den-
sity of 1.0U104 cells/cm2, and grown to con£uence in Dulbecco’s
modi¢ed Eagle’s medium (DMEM), supplemented with 10% (v/v)
newborn calf serum (NCS). Con£uent cells were subsequently made
quiescent by incubation in serum-free medium (SF) consisting of a 1:1
mixture of DMEM and Ham’s F-12 medium, supplemented with
30 nM Na2SeO3 and 10 Wg/ml human transferrin for 3 days [13].
2.1.2. Anchorage independent growth. Tissue culture plates were
coated with poly (2-hydroxyethyl-methacrylate), abbreviated as
poly-HEMA, in ethanol as described [18]. One day before each experi-
ment, con£uent NRK cell cultures were trypsinized and replated at
50% con£uence in order to obtain single cells in a subcon£uent, pro-
liferating culture. The next day, cells were trypsinized again and
seeded in SF medium supplemented with 5 Wg/ml insulin, 0.2% bovine
serum albumin (BSA), and 10% (v/v) growth factor inactivated fetal
calf serum (SFS medium) [19].
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2.2. MTT assay for anchorage independent growth
A total of 1.5U104 cells were seeded in 130 Wl per well of SFS
medium in 96-well tissue culture plates coated with poly-HEMA. Sub-
sequently, growth factors to be tested were added to the cells in 20 Wl
binding bu¡er (DMEM supplemented with 0.1% BSA and 50 mM
BES, pH 6.8; see [19]). After incubation for 5 days, 15 Wl MTT ((3-
(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide), 5 mg/ml)
in phosphate bu¡ered saline (PBS) was added and incubated for 4 h.
The produced MTT formazan was solubilized by addition of 100 Wl of
SDS solution (20% (w/v) sodium dodecyl sulfate in 0.1 M HAc), and
the absorbance was measured after 24 h at 570 nm, relative to the
absorbance at 690 nm, using a microplate reader [18].
2.3. EGF receptor promoter activity
2.3.1. Vectors. EGF receptor gene promoter activity: Luciferase
reporter gene vector pSVOALv5P containing the 5P region of the
human EGF receptor gene (31100 to 319 relative to the ATG trans-
lation site) [20] was kindly provided by Dr. G.N. Gill (University of
California, San Diego, CA, USA). PDGF K-receptor gene promoter
activity: Luciferase reporter gene vector (pSLA4) containing the 3441
to +118 region of the human platelet derived growth factor K-receptor
(PDGFKR) gene promoter (3441/+118LUC) [21]. To allow for selec-
tion of stable transfectants, a neomycin resistance encoding vector
(pcDNA I/NEO, Invitrogen) was cotransfected.
2.3.2. Transfections. NRK cells were seeded at a density of
4.0U104 cells/cm2 in 80 cm2 tissue culture dishes, 1 day prior to
transfection. Plasmid DNA was transfected using the calcium phos-
phate precipitate method [22]. Subsequently, the cells were incubated
for 3 days in DMEM+10% NCS, after which 700 Wg/ml geneticin was
added to start the selection of the transfected cells. The surviving cells
were trypsinized and cultured in the presence of geneticin (300 Wg/ml)
for 3 weeks.
2.3.3. Assay of luciferase activity. The stably transfected cells were
cultured under the same experimental conditions as described above
for the parental cells. Luciferase activity was assayed in a LKB 1250
luminometer, using the Promega luciferase assay kit. Luciferase activ-
ity was corrected for cell numbers by measuring protein concentra-
tions according to the Lowry method using BSA as standard.
2.4. mRNA expression
EGF receptor mRNA expression was monitored semi-quantita-
tively by the ‘primer-dropping’ RT-PCR method which makes it pos-
sible to distinguish changes in gene expression of less than twofold to
greater than 75-fold [23]. Optimal cycle numbers were determined as
described [23]. Under these conditions competitive interference was
absent and twofold changes in the abundance of PCR products
were detected over a span of 4^5 cycles, making this method suitable
to monitor EGF receptor mRNA expression [14].
2.5. EGF binding studies in non-adherent cells
A total of 0.5U106 cells were seeded in 1 ml SFS medium in 24-well
tissue culture plates (adherent) or in 24-well tissue culture plates
coated with poly-HEMA (non-adherent) and treated for 48 h with
the indicated factors. After washing the cells three times with binding
bu¡er, the medium was changed for 0.5 ml of binding bu¡er now
containing in addition 4 ng/ml murine 125I-EGF (a gift from Dr. T.
Benraad, Department of Endocrinology, University of Nijmegen, The
Netherlands). Non-speci¢c binding was determined by a parallel treat-
ment with a 100-fold excess of unlabelled EGF. The cells were incu-
bated for 1 h at room temperature after which they were washed three
times with PBS containing 0.1% BSA, three times with PBS and sub-
sequently extracted with 1% (v/v) Triton X-100, prior to Q-counting
[24]. 125I-EGF binding was corrected for cell numbers by measuring
protein concentrations according to the Lowry method using BSA as
standard.
2.6. Materials
TGF-L1 was from RpD Systems. Bradykinin (BK), lysophospha-
tidic acid (LPA), prostaglandin F2K (PGF2K), RA, transferrin, MTT,
and BSA were from Sigma. Endothelin-1 (ET-1) was from Peninsula
Laboratories Europe. DMEM and Ham’s F-12 medium were from
Gibco, NCS from Hyclone, and poly-HEMA from Aldrich-Chemie,
Germany.
3. Results
3.1. EGF receptor mRNA, EGF receptor promoter activity and
125I-EGF binding are decreased in anchorage independent
cultures of NRK cells
Fig. 1 shows EGF receptor mRNA levels, measured by the
‘primer-dropping’ RT-PCR method, in NRK cells that had
been cultured for 3 days on poly-HEMA coated dishes. The
data indicate a 2.5-fold reduction in mRNA levels in anchor-
age independent cells when compared to quiescent monolayer
cells. When cells were grown on poly-HEMA coated dishes in
the presence of EGF and RA, a combination of factors that
induces AIG of NRK cells, no such reduction in EGF recep-
tor mRNA levels was observed.
In order to study if the above reduction in mRNA levels
under anchorage independent conditions is due to a repression
of transcriptional activity, the activity of an EGF receptor
promoter construct linked to luciferase was studied after sta-
ble transfection into NRK cells. Fig. 2 shows that basal EGF
receptor promoter activity decreased in a time dependent
manner after substrate release, resulting in approximately
10% of its original value after 72 h of incubation. Re-adher-
ence of the same cells resulted in a time dependent restoration
of EGF receptor promoter activity, demonstrating that the
reduction in activity upon substrate release is not due to cell
death. Moreover, a similar reporter construct based on the
platelet derived growth factor K-receptor promoter was
much less a¡ected by cell adherence, indicating that the e¡ects
observed do not result from a general inhibition of macro-
molecule biosynthesis. In Fig. 3 it is shown that this decrease
of EGF receptor promoter activity is parallelled by a decrease
of 125I-EGF binding. These data show that EGF receptor
expression levels are strongly a¡ected by cell adherence. Sim-
ilar e¡ects on EGF receptor expression have been obtained by
Mansbridge et al. [25] who showed a strongly decreased bind-
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Fig. 1. E¡ect of cell anchorage on EGF receptor mRNA levels in
NRK cells. NRK cells were cultured for 3 days on poly-HEMA
coated dishes in SFS medium (poly-HEMA) in the absence (Con-
trol) or presence of 50 ng/ml RA and 5 ng/ml EGF (RA+EGF), or
were cultured as monolayer cells and incubated in SF medium for
3 days (Quiescent monolayer). Indicated standard errors of the
mean are based on at least ¢ve experiments.
D.H.T.P. Lahaye et al./FEBS Letters 446 (1999) 256^260 257
ing of 125I-EGF to A431 cells when grown in spheroids, in
contrast to those of Ness et al. [26] who observed an increase
in EGF receptor mRNA levels in glioma cells cultured with-
out anchorage.
3.2. Induction of anchorage independent growth of NRK cells is
parallelled by increased EGF receptor promoter activity
and increased 125I-EGF binding
Besides RA and TGF-L, several other factors have been
shown to induce phenotypic transformation of NRK cells in
the presence of EGF, including BK, PGF2K, ET-1, and LPA
[24,27^29]. When tested on quiescent monolayer cells and
density arrested cells, these various factors have been shown
to enhance EGF receptor levels [14]. In order to study if these
factors are also able to enhance EGF receptor expression in
anchorage independent cells, we used the above cells stably
transfected with the EGF receptor promoter linked to lucifer-
ase. Fig. 4 shows a comparison between the ability of these
factors to induce AIG of NRK cells and their ability to en-
hance EGF promoter activity in anchorage independent cul-
tures of these cells. The data presented show that ET-1,
TGFL, and PGF2K strongly increase both EGF dependent
AIG and EGF receptor promoter activity, while BK, LPA,
and RA have only a minor e¡ect in both assays. Similar
results were obtained when colony formation in soft agar
was measured instead of proliferation on poly-HEMA coated
dishes (data not shown). Also in anchorage independent cells
which were ¢rst cultured for 48 h in the absence of growth
factors, EGF receptor promoter activity and AIG could still
be induced upon subsequent growth factor treatment (data
not shown), indicating these growth factors can up-regulate
EGF receptor promoter activity even after the initial decrease
observed upon loss of anchorage. 125I-EGF binding studies
show (Fig. 3) that particularly PGF2K and TGF-L strongly
enhance the number of EGF receptors in anchorage independ-
ent NRK cells, in parallel with their activity on EGF receptor
promoter activity (Fig. 4A). RA was less active in both assays,
but clearly more potent in the binding assay than in the pro-
moter assay. The same disconnection between the induction of
EGF receptor promoter activity and AIG can be seen in the
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Fig. 4. E¡ect of phenotypic transformation inducing agents on EGF
receptor promoter activity in anchorage independent NRK cells
compared to their ability to induce anchorage independent prolifera-
tion. A: EGF receptor promoter activity. NRK cells were seeded on
poly-HEMA coated dishes in the presence of 1 WM BK, 1 WM
PGF2K, 0.1 WM ET-1, 100 WM LPA, 50 ng/ml RA, 1 ng/ml TGF-L,
5 ng/ml EGF, or in the absence of factors (Cont) in SFS medium.
After incubation for 2 days, EGF receptor promoter activity was
measured and corrected for cell numbers. Indicated standard errors
of the mean are based on triplicate experiments. B: Anchorage inde-
pendent proliferation. NRK cells were seeded on poly-HEMA
coated dishes in the presence of 5 ng/ml EGF and the indicated fac-
tors, or in the complete absence of factors (Cont) in SFS medium.
After incubation for 5 days, cell numbers were measured using the
MTT assay. Indicated standard errors of the mean are based on
quadruplicate experiments.
Fig. 3. E¡ect of anchorage independent culturing and phenotypic
transformation inducing agents on EGF binding in NRK cells.
NRK cells were seeded on culture dishes (adherent) or on poly-
HEMA coated dishes (non-adherent), the latter in the presence of 1
WM PGF2K, 50 ng/ml RA, or 1 ng/ml TGF-L, or without additional
factors (control) in SFS medium. After incubation for 2 days, 125I-
EGF (4 ng/ml) binding was determined and corrected for non-spe-
ci¢c binding. Data are expressed relative to the number of cells de-
termined by protein analysis. Indicated standard errors are based on
duplicate experiments.
Fig. 2. In£uence of anchorage independent culturing of NRK cells
and subsequent re-adherence on EGF receptor promoter activity.
EGF receptor (solid line) or PDGFK receptor (dashed line) pro-
moter activity measured as a function of time after seeding the (sta-
bly transfected) cells on poly-HEMA coated dishes in SFS medium.
After 3 days, the non-adherent NRK cells were allowed to re-attach
in the same medium and luciferase activity was measured for anoth-
er 3 days. Indicated standard errors of the mean are based on tripli-
cate experiments.
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case of stimulation with LPA. This discrepancy will be dis-
cussed.
4. Discussion
NRK ¢broblasts are unique in that their proliferation is
strongly stimulated by EGF, while this growth factor is un-
able to induce a transformed phenotype in these cells. In our
previous studies we have shown [14] that pretreatment of qui-
escent NRK cells with agents that enhance EGF receptor
levels increases the mitogenic potential of EGF in these cells,
indicating that the number of EGF receptors limits the mito-
genic activity of this growth factor. Moreover, addition of
such factors to con£uent monolayer cultures is essential to
induce phenotypic transformation of EGF treated NRK cells,
by preventing them from becoming density arrested. In the
present study we have shown that, similar to culturing at
high cell density, also anchorage independent culturing of
NRK cells results in a strong reduction of EGF receptor ex-
pression levels. As a consequence, treatment of anchorage
independent cells with EGF alone is insu⁄cient to induce
these cells to proliferate. However, treatment of these cells
with the modulating factors that are known to increase
EGF receptor expression in monolayer cells results in anchor-
age independent growth of EGF treated cells. This shows that
the growth factor requirements for loss of density dependent
growth inhibition and anchorage independent growth of
NRK cells are very similar and that in both cases EGF in-
duced proliferation very likely relies on su⁄ciently high EGF
receptor levels.
In this study, we have used NRK cells stably transfected
with the 5P-region of the human EGF receptor gene linked to
luciferase to study the e¡ects of modulating factors on EGF
receptor promoter activity. Previous studies have indicated
that this promoter construct is sensitive to stimulation by
EGF itself, phorbol 12-myristate 13-acetate (PMA),
(Bu)2cAMP, dexamethasone [20], and TGF-L [5,30]. RA has
been shown to have both activating [20] and repressing [31]
activity on the EGF receptor promoter, while expression stud-
ies have indicated that agents which induce PtdIns(4,5)P2 hy-
drolysis in rat liver epithelial cells are able to increase EGF
receptor mRNA levels in these cells [32]. We have previously
shown that ET-1 and PGF2K are both very strong inducers of
PtdIns(4,5)P2 hydrolysis in substrate attached NRK cells,
while BK and LPA have only poor activity [16]. These results
correlate very well with our current results on induction of
EGF receptor promoter activity in anchorage independent
cells.
Our present binding studies with radiolabeled EGF have
indicated that RA upregulates EGF receptor mRNA and pro-
tein levels not only in monolayer NRK cells [14,29,33] but
also in anchorage independent cells (Fig. 3). This increase of
125I-EGF binding is parallelled by induction of AIG (Fig. 4B),
but not necessarily by a comparable increase of EGF receptor
promoter activity (Fig. 4A). This could be due to the fact that
important RA inducible elements for positive regulation of
EGF receptor expression in NRK cells are lacking in the
promoter construct tested here, as indicated in earlier studies
[34]. Nevertheless, in adherent NRK cells, EGF receptor pro-
moter activity is strongly increased by RA [16]. This does not
exclude the possibility, however, that important RA inducible
elements for positive regulation of EGF receptor expression in
non-adherent NRK cells are lacking in the promoter construct
tested here. The strong increase of EGF receptor mRNA lev-
els by RA in the presence of EGF (Fig. 1) underlines this
statement. The same contrast between induction of EGF re-
ceptor promoter activity and AIG was seen when the cells
were stimulated with LPA, indicating that the correlation be-
tween EGF receptor levels and EGF receptor promoter activ-
ity is only observed whit speci¢c stimuli, in particular TGFL
and PtdIns(4,5)P2 hydrolysing agents such as ET-1 and
PGF2K.
Our present 125I-EGF binding studies show that the de-
crease of EGF receptor mRNA levels and promoter activity
is parallelled by a decrease of 125I-EGF binding, while factors
that induce AIG also increase 125I-EGF binding. Most likely
these binding studies tend to underestimate the e¡ects of the
modulating agents tested on EGF receptor expression, since
anchorage independent NRK cells have a tendency to form
clusters that have a limited penetration of EGF [35]. In our
experience and that of others (reviewed in [15]) it is di⁄cult,
however, to quantitatively determine EGF receptor levels in
NRK cells by other techniques, e.g. using immunological tech-
niques, because of the very low receptor numbers present.
Our data show that EGF itself is able to increase EGF
receptor promoter activity in NRK cells to a level which is
comparable to that induced by PGF2K. In many cell types,
including monolayer NRK cells [33], EGF is able to enhance
EGF receptor mRNA levels [32,33,36], receptor protein levels
[32], and receptor gene promoter activity [20], acting at both
the transcriptional [20,33] and post-transcriptional [36] level.
However, EGF by itself is able neither to induce anchorage
independent proliferation of NRK cells, nor to induce prolif-
eration of density arrested cells. This shows that an increase of
EGF receptor numbers alone may not necessarily be su⁄cient
to induce AIG of NRK cells and that additional signalling
pathways may be involved. Nevertheless, the present data
strongly suggest that an increase of EGF receptor numbers
is a prerequisite for the induction of anchorage independent
growth.
Several other mechanisms have been proposed to play a
role in the induction of AIG of NRK cells. The induction
of extracellular matrix proteins such as ¢bronectin has been
shown to accompany the induction of AIG by TGF-L [4,5].
However, not all phenotypic transformation inducing factors
increase ¢bronectin gene expression [5,10], showing that the
production of extracellular matrix proteins is not obligatory
for AIG. Furthermore, ¢bronectin is unable to replace TGFL
in inducing AIG of EGF treated NRK cells ([37] and E.J.J.
van Zoelen, unpublished data). Another mechanism proposed
is the modulation of protein-tyrosine phosphatase (PTPase)
activity [10], since inhibition of PTPases leads to induction
of AIG [10] and overexpression of the tyrosine and threonine
speci¢c cdc25 phosphatase is involved in the induction of AIG
[11]. Furthermore, a CTGF dependent signalling pathway
seems to be involved in TGF-L induced AIG of NRK cells
[9]. Other studies show that the expression of cyclin A plays
an important role in the regulation of AIG in NRK cells. The
expression is suppressed when NRK cells are suspended while
ectopic expression of cyclin A bypasses the adhesion require-
ment [7]. The regulation of cyclin A expression by adhesion is
mediated at the transcriptional level [38], suggesting that pro-
teins that are present prior to the appearance of cyclin A
during cell cycle progression are targets of the adhesion signal
FEBS 21684 15-3-99
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[39]. Unlike observations on other cell types [8,40], cyclin D1
levels or activity of the cyclin E/cdk2 complex do not appear
to play a role in the induction of AIG of NRK cells [8]. It
should be realized, however, that most of the studies men-
tioned on AIG of NRK cells have been carried out in the
presence of serum containing medium with its variety of
growth factors. Our previous studies on density dependent
growth arrest of NRK cells and our current ones on AIG
have all been carried out under growth factor de¢ned culture
conditions, to allow studies on the e¡ects of EGF as the only
growth stimulating hormone present.
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